NEW YORK, Nov. 23 (GenomeWeb News) - Shares in Nanogen were up 5.24 percent at $4.02 in heavy mid-afternoon trading as investors cheered a new patent the company won in the United States for DNA microarrays.

 

The stock briefly climbed to $4.20 earlier in the day, and trading volume hovered around 1.4 million shares, almost two-and-a-half times their average volume.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.